The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|2|3|191-200

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.2, Iss.3, 2003-06, pp. : 191-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1549-1559

Bentham Science Publishers

Access to resources Recommend Favorite

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

The Involvement of the Vasopressin System in Stress-Related Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 167-179

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1647-1674

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress-Related Molecules as a Therapeutic Target for Inflammatory and Allergic Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 4, 2005-08 ,pp. : 511-515

Bentham Science Publishers

Access to resources Recommend Favorite